"Recommendation:
· We reiterate our unchanged Buy recommendation for LYC, with an increased price target of $2.85/share, in line with our DCF valuation.
· Key catalysts for the stock include: achieving increased production targets, maintaining current cost profile and EBITDA margin; supportive NdPr oxide prices; continued deleveraging of the company; updates on long term agreements."
Mehr Details im PDF
www.fostock.com.au/LiteratureRetrieve.aspx?ID=243131
· We reiterate our unchanged Buy recommendation for LYC, with an increased price target of $2.85/share, in line with our DCF valuation.
· Key catalysts for the stock include: achieving increased production targets, maintaining current cost profile and EBITDA margin; supportive NdPr oxide prices; continued deleveraging of the company; updates on long term agreements."
Mehr Details im PDF
www.fostock.com.au/LiteratureRetrieve.aspx?ID=243131